Why Is Teva Pharmaceutical Projecting a Revenue Trough in 2019?

Why Is Teva Pharmaceutical Projecting a Revenue Trough in 2019?

Is Teva Pharmaceutical an Attractive Pick This February?(Continued from Prior Part)Revenue performance in 2018 In its fourth-quarter earnings investor presentation, Teva Pharmaceutical (TEVA) guided for revenue of $17.0 billion–$17.4 billion in